Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Lakewood-Amedex Biotherapeutics Inc. - Common Stock
(NQ:
LABT
)
0.9400
-0.0153 (-1.60%)
Delayed Quote
Updated: 2:18 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
148,635
Open
0.9444
Bid (Size)
0.9300 (500)
Ask (Size)
0.9500 (2,100)
Prev. Close
0.9553
Today's Range
0.9100 - 0.9554
52wk Range
0.9200 - 98.20
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
September 28, 2026
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced positive Minimum Inhibitory Concentration (MIC) data from recent clinical isolates for its lead clinical candidate, Nu-3.
Via
B2i Digital
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
September 28, 2026
Via
Chartmill
Performance
YTD
-98.9%
-98.9%
1 Month
-62.4%
-62.4%
3 Month
-71.5%
-71.5%
6 Month
-98.9%
-98.9%
1 Year
-98.9%
-98.9%
More News
Read More
These stocks are moving in today's pre-market session
↗
September 28, 2026
Via
Chartmill
Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers
September 24, 2026
Via
B2i Digital
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
September 21, 2026
Via
B2i Digital
Topics
Intellectual Property
Lakewood-Amedex announces IRB approval and clinical site readiness for the Phase 2a trial of Nu-3
September 18, 2026
Via
B2i Digital
The trading volume of these stocks is deviating from the norm in today's session.
↗
September 01, 2026
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 01, 2026
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 31, 2026
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
August 31, 2026
Via
Chartmill
Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company
August 25, 2026
Via
NewMediaWire
Topics
Derivatives
Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now
July 23, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Top movers analysis one hour before the close of the markets on 2026-07-22: top gainers and losers in today's session.
↗
July 22, 2026
Via
Chartmill
Curious about the most active stocks on Wednesday?
↗
July 22, 2026
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 22, 2026
Via
Benzinga
Top movers analysis in the middle of the day on 2026-07-22: top gainers and losers in today's session.
↗
July 22, 2026
Via
Chartmill
Gapping stocks in Wednesday's session
↗
July 22, 2026
Via
Chartmill
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Frequently Asked Questions
Is Lakewood-Amedex Biotherapeutics Inc. - Common Stock publicly traded?
Yes, Lakewood-Amedex Biotherapeutics Inc. - Common Stock is publicly traded.
What exchange does Lakewood-Amedex Biotherapeutics Inc. - Common Stock trade on?
Lakewood-Amedex Biotherapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock is LABT on the Nasdaq Stock Market
What is the current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock is 0.9400
When was Lakewood-Amedex Biotherapeutics Inc. - Common Stock last traded?
The last trade of Lakewood-Amedex Biotherapeutics Inc. - Common Stock was at 10/01/26 02:18 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.